Combangio
About:
Combangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics.
Top Investors: California Institute for Regenerative Medicine
Description:
Combangio is a clinical-stage biotechnology company focused on developing regenerative biotherapeutics based on mesenchymal stem cell secretomes.
Total Funding Amount:
$15M
Headquarters Location:
California, Kentucky, United States
Founded Date:
2014-01-01
Founders:
Number of Employees:
Last Funding Date:
2023-04-01
IPO Status:
Private
Industries:
© 2025 bioDAO.ai